OraQuick(R) In-Home HIV Test Launches New Targeted Campaign

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
OraQuick(R) In-Home HIV Test Launches New Targeted Campaign Strategy -- "Life. As we know it.(TM)" Encourages HIV Testing Among High Risk Groups

BETHLEHEM, Pa., Sept. 30, 2013 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq: OSUR ), makers of the OraQuick ® In-Home HIV Test , announced today the launch of its newly revamped targeted nationwide awareness campaign to encourage open and honest dialogue about sexual health and the importance of learning your HIV status.

The "Life. As we know it." campaign takes a bold new strategic approach to reaching consumers most at risk for HIV through the creation and sharing of relevant content designed to engage consumers in a discussion about topics related to love, sex, relationships and sexual health.

Initially, the campaign will reach out to two groups among those at highest risk for HIV – gay men and African American women. OraSure has teamed up with powerful and influential voices to reach consumers in these communities through testimonials, interactive panel discussions, sharable discussion guides and informative videos. The campaign will also use leading media properties to communicate with these communities, including LOGO TV and its online properties for the gay community – a network that reaches into over 52 million homes – and Essence , the top-rated media brand for African American women.

"HIV testing is a challenging subject to address head on with consumers. After a careful analysis of available channels to gain mindshare of our target markets, we've determined that the most effective way to approach the topic is through a broader conversation on relationships, dating and sex, and through the engagement of passionate, trusted community influencers to help us introduce product," said Kathleen Weber, Senior Vice President and General Manager, Consumer Products at OraSure Technologies.

The campaign will also feature engagement in high profile consumer events, as well as targeted broadcast, outdoor, digital and print advertising through the first half of 2014.

Television host and best-selling author Ross Mathews has teamed with OraSure to kick off the campaign to the gay community which launched on September 27 th , in conjunction with National Gay Men's HIV/AIDS Awareness Day.

Mathews debuted on television as a correspondent for "The Tonight Show with Jay Leno" in 2001. Mathews then became a regular panelist and occasional guest host on E!'s talk show "Chelsea Lately," and remains a fixture on E! News and E! Network's live red carpet awards show coverage.  Mathews recently added best-selling author to his resume with his first book, Man Up: Tales of My Delusional Self-Confidence , released in May. He currently stars in and produces his own weekly talk show, "Hello Ross!" for E!.  "Hello Ross!" is the new weekly fan destination where the intersections of celebrity gossip and pop culture collide, hosted by the world's biggest super fan himself, Mathews.

He will be joined throughout the campaign by influential members of the gay community to talk about topics such as sex, love, health and the importance of testing for HIV. OraSure is also proud to be a sponsor of RuPaul's Drag Race – the most watched series on LOGO TV. Working with LOGO, the Company is also developing custom co-branded content that will air on the network. The campaign will also have a very active and visible presence on the ground at Gay Pride events being held in eight major U.S. cities over the next year.  Additionally, the campaign will reach gay men in the top 15 markets via out of home advertising (billboards, bus shelters and posters) placed in key neighborhoods such as West Hollywood, South Beach, Miami and the Castro in San Francisco and print advertising in over 40 gay-targeted publications.

To engage the African American community, the "Life. As we know it." campaign will feature a dynamic, timely, new web series that will entertain, inform and engage today's modern African American woman with candid, real talk about life, love and sex. The inviting and uplifting interactive panel conversations will be structured like a talk show and will be hosted by an esteemed trio of celebrity panelists from the community including physician, sex expert and co-host of nationally-syndicated television show The Doctors Dr. Rachael Ross , author, life coach and relationship expert Demetria L. Lucas and national television/radio personality and veteran journalist Jacque Reid . 

  • Dr. Rachael Ross, a family doctor and sexologist, is a forerunner of groundbreaking discussions surrounding relationships, sex, health, abstinence & comprehensive sex education for teenagers, and most importantly HIV/AIDS prevention. Dr. Rachael tours college campuses to speak, is frequently quoted in Cosmopolitan and Self Magazine , contributes to several medical publications, is often a featured guest on the nationally syndicated Tom Joyner Morning Show, and just became a co-host on the nationally syndicated television show, The Doctors .
     
  • Demetria L. Lucas, the author of "A Belle in Brooklyn: The Go-to Girl for Advice on Living Your Best Single Life (Atria)", is the creator of the award-winning personal blog ABelleInBrooklyn.com and the founder of Coached By Belle, a boutique life-coaching service. Lucas, chosen as one of Essence.com's "40 Fierce & Fab Under 40", is also a contributing editor for The Root , and is a contributing writer for the websites of The Grio, XO Jane, Essence, Clutch, Vibe Vixen and Uptown.
     
  • Jacque Reid, a veteran journalist with a background in entertainment and news, has interviewed some of the world's most influential and interesting people. Currently, Jacque serves as a daily co-host on NBC's celebrity and lifestyle show, New York Live and is a regular part of the nationally syndicated radio program, The Tom Joyner Morning Show. Reid reports on women and women's issues on her Inside Her Story segments.

The conversations, which will be hosted in conjunction with major events throughout the country, will focus on life, relationships, sexual health and the importance of testing for HIV. Video captured from these conversations, will be featured as a web series on Essence.com and also be housed on a dedicated campaign website.

The web series will kick off with a panel events taking place in October – October 4 th at the Blogalicious conference in Atlanta, October 20 th at the Circle of Sisters Expo in New York City, and October 22 nd at the 2013 Spelman College and Morehouse College Homecoming in Atlanta. More information will be posted on October 4 th to the campaign website at www.whatsworthknowing.com/women .

The fall schedule of activity will culminate with a panel event and media day, featuring Magic "Earvin" Johnson on November 19 th in New York City in recognition of World AIDS Day which is held annually on December 1 st . 

"Through the use of our OraQuick ® In-Home HIV Test, we believe more than 200,000 individuals now know their HIV status," said Douglas A. Michels, President and Chief Executive Officer of OraSure Technologies. "The more we can find ways to start conversations about HIV testing, especially among the communities most impacted by HIV, the better the chance there is to stop the spread of HIV." 

The OraQuick® In-Home HIV Test is the first ever in-home rapid HIV test made available directly to consumers. It detects antibodies to both HIV-1 and HIV-2 with an oral swab, providing a safe, effective and confidential in-home testing option with results in as little as 20 minutes. It is available in most national drugstore and mass merchandiser retail outlets nationwide and online at CVS/CVS.com, Rite Aid/RiteAid.com, Walgreens/Walgreens.com, Walmart/Walmart.com, and on Drugstore.com and OraQuick.com. The OraQuick® In-Home HIV Test is an over-the-counter version of OraQuick ADVANCE®, an oral swab rapid test with more than 25 million units sold in the professional market, and the same test that doctors and healthcare professionals have relied on and used for 10 years. 

To ensure optimal support for individuals using the OraQuick® In-Home HIV Test, OraSure offers live support and comprehensive referral services 24 hours a day, seven days a week, every day of the year, through a toll-free support center and consumer website at www.oraquick.com . The OraQuick® Support Center is staffed with bi-lingual (English/Spanish) representatives who are available by telephone at 866-436-6527 to answer questions about HIV/AIDS and using and interpreting the test. They also provide referrals to follow-up and care, and can take orders for the OraQuick In-Home HIV Test. Additionally, the product website provides access to resources and referral to follow-up counseling, confirmatory testing and medical care.

For more information on OraQuick visit OraQuick.com .

About OraSure Technologies

OraSure Technologies is a leader in the development, manufacture and distribution of oral fluid diagnostic and collection devices and other technologies designed to detect or diagnose critical medical conditions. Its innovative products include rapid tests for the detection of antibodies to HIV and HCV at the point of care and testing solutions for detecting various drugs of abuse. In July 2012, the Company received approval from the U.S. Food and Drug Administration for the Company's OraQuick® In-Home HIV Test for sale directly to consumers in the over-the-counter (OTC) market - making it the first and only rapid OTC HIV test approved in the U.S. In addition, the Company is a leading provider of oral fluid sample collection, stabilization and preparation products for molecular diagnostic applications. OraSure's portfolio of products is sold globally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, research and academic institutions, distributors, government agencies, physicians' offices, and commercial and industrial entities. The Company's products enable healthcare providers to deliver critical information to patients, empowering them to make decisions to improve and protect their health.

For more information on OraSure Technologies, please visit www.orasure.com .

Media Contact: Jennifer Moritz Zer0 to 5ive for OraSure Technologies 917-748-4006 Investor Contact: Ron Spair Chief Financial Officer 610-882-1820

Scroll down for more posts ▼

Top 10 Most Recent News Articles

NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 14

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 9

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 14

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 17

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 12

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 11

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 8

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 11

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 12

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

Semtech Corporation Faces Legal Challenge: Shareholder Rights Explained

Updated Category News Views 145

Understanding the Current Legal Landscape for Semtech Corporation Semtech Corporation, a notable player in the semiconductor industry, is currently embroiled in a significant class action lawsuit concerning alleged violations of federal securities laws. This legal action has garnered the attention of investors and shareholders alike, prompting them to seek clarity on...

Continue Reading
Breezeline Expands Fiber Internet Access in New Hampshire

Updated Category News Views 194

Breezeline's Commitment to Fiber Internet Expansion Breezeline is actively enhancing its service offerings by deploying fiber-to-the-home internet in several communities across New Hampshire. This exciting initiative aims to connect towns such as Barnstead, Farmington, Franklin, Milton, Northfield, Pittsfield, Rochester, Tilton, and Wolfeboro with high-speed internet. As...

Continue Reading
Investigation into Cepton, Inc.'s Share Sale: What's Next for Investors?

Updated Category News Views 78

Cepton, Inc. (NASDAQ: CPTN) got itself tangled in a mess back when it sold to KOITO MANUFACTURING CO., LTD. for $3.17 per share. Traders were quick on the draw as Halper Sadeh LLC kicked off an investigation into whether that price was just or a complete rip-off for shareholders. The heart of the issue? Was Cepton’s board really looking out for their shareholders’...

Continue Reading
Affordable 5G Solutions for Low-Income Households Set to Transform Lives

Updated Category News Views 218

Mission Telecom Partners with Computers 4 People This innovative partnership is set to eliminate significant barriers to affordable broadband for low-income households. By dramatically reducing hardware costs, these organizations aim to transform internet access across communities. An Unprecedented Move Towards Digital Equity The collaboration between Mission Telecom and...

Continue Reading
KPN's Strategy and Progress on €250 Million Share Buyback

Updated Category News Views 139

KPN's Strategic Share Buyback Initiative KPN is making notable strides with its €250 million share buyback program. Recently, the company repurchased a significant amount of its ordinary shares from March 24 to March 28. This specific buyback involved 2,020,000 shares, purchased at an average price of €3.84 per share, totaling approximately €7.8 million. These...

Continue Reading